Group One Trading’s Dianthus Therapeutics DNTH Stock Holding History

Group One Trading’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$244K	Hold	2,500	–	–	﹤0.01%	4135
2026 Q1	$210K	Sell	2,500 -300	-11%	-$17.4K	﹤0.01%	4075
2025 Q4	$115K	Sell	2,800 -42,800	-94%	-$1.66M	﹤0.01%	4876
2025 Q3	$1.79M	Buy	45,600 +20,900	+85%	+$534K	﹤0.01%	2425
2025 Q2	$460K	Buy	+24,700	New	+$463K	﹤0.01%	3501
2021 Q3	–	Sell	-6	Closed	-$1K	–	8286
2021 Q2	$1K	Sell	6 -2,188	-100%	-$402K	﹤0.01%	8002
2021 Q1	$416K	Buy	2,194 +1,825	+495%	+$307K	﹤0.01%	4255
2020 Q4	$46K	Buy	369 +344	+1,376%	+$39K	﹤0.01%	5053
2020 Q3	$3K	Sell	25 -6	-19%	-$711	﹤0.01%	5738
2020 Q2	$4K	Buy	31 +25	+417%	+$3.52K	﹤0.01%	5413
2020 Q1	$1K	Hold	6	–	–	﹤0.01%	5065
2019 Q4	$2K	Buy	+6	New	+$1.12K	﹤0.01%	4888

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Group One Trading's DNTH Position: Q2 2026 in Review

Group One Trading reduced its Dianthus Therapeutics (DNTH) stake by 97% in Q2 2026, selling an estimated $294K and leaving 89 shares worth $8.68K. The position accounts for ﹤0.01% of the portfolio, ranked #6480.

Group One Trading first reported a position in DNTH in Q4 2019 and has held it in 7 quarters since. The position peaked at $290K in Q1 2026. 269 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

Group One Trading held 89 shares of Dianthus Therapeutics worth $8.68K as of Q2 2026.
Group One Trading sold 3,364 Dianthus Therapeutics shares in Q2 2026, an estimated $294K.
Dianthus Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6480 holding.
Group One Trading first reported a position in Dianthus Therapeutics in Q4 2019 and has held it in 7 quarters since.
Group One Trading's Dianthus Therapeutics position peaked at $290K in Q1 2026.
269 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.